Utilizing population variation, vaccination, and systems biology to study human immunology

Trends in Immunology

Volumn 36, Issue 8, 2015, Pages 479-493

  Tsang, John S ^a,b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTRINSIC FACTOR;

AGE; ANTIBODY TITER; BODY MASS; GENDER; GENETICS; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOLOGY; INFECTION; NATURAL POPULATION; NONHUMAN; PREDICTION; REVIEW; SYSTEMS BIOLOGY; VACCINATION; IMMUNE SYSTEM;

HUMANS; IMMUNE SYSTEM; SYSTEMS BIOLOGY; VACCINATION;

EID: 84939492863     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2015.06.005     Document Type: Review

References (131)

1. Germain R.N., Schwartzberg P.L. The human condition: an immunological perspective. Nat. Immunol. 2011, 12:369-372.
2. Davis M.M. A prescription for human immunology. Immunity 2008, 29:835-838.
3. Chaussabel D., et al. Assessing the human immune system through blood transcriptomics. BMC Biol. 2010, 8:84.
4. Kingsmore S.F. Multiplexed protein measurement: technologies and applications of protein and antibody arrays. Nat. Rev. Drug Discov. 2006, 5:310-321.
5. Shendure J., Aiden E.L. The expanding scope of DNA sequencing. Nat. Biotechnol. 2012, 30:1084-1094.
6. Shalek A.K., et al. Single-cell transcriptomics reveals bimodality in expression and splicing in immune cells. Nature 2013, 498:236-240.
7. Bendall S.C., et al. A deep profiler's guide to cytometry. Trends Immunol. 2012, 33:323-332.
8. Stegle O., et al. Computational and analytical challenges in single-cell transcriptomics. Nat. Rev. Genet. 2015, 16:133-145.
9. Chaussabel D., Baldwin N. Democratizing systems immunology with modular transcriptional repertoire analyses. Nat. Rev. Immunol. 2014, 14:271-280.
10. Li S., et al. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat. Immunol. 2014, 15:195-204.
11. Shen-Orr S.S., et al. Cell type-specific gene expression differences in complex tissues. Nat. Methods 2010, 7:287-289.
12. Germain R.N., et al. Systems biology in immunology - a computational modeling perspective. Annu. Rev. Immunol. 2011, 29:527-585.
13. Tsang J.S., et al. Global analyses of human immune variation reveal baseline predictors of postvaccination responses. Cell 2014, 157:499-513.
14. Bendall S.C., et al. Single-cell trajectory detection uncovers progression and regulatory coordination in human B Cell development. Cell 2014, 157:714-725.
15. Qiu P., et al. Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE. Nat. Biotechnol. 2011, 29:886-891.
16. Aghaeepour N., et al. Critical assessment of automated flow cytometry data analysis techniques. Nat. Methods 2013, 10:228-238.
17. Shekhar K., et al. Automatic classification of cellular expression by nonlinear stochastic embedding (ACCENSE). Proc. Natl. Acad. Sci. U.S.A. 2014, 111:202-207.
18. Furman D., et al. Apoptosis and other immune biomarkers predict influenza vaccine responsiveness. Mol. Syst. Biol. 2013, 9:659.
19. Nakaya H.I., et al. Systems biology of vaccination for seasonal influenza in humans. Nat. Immunol. 2011, 12:786-795.
20. Querec T.D., et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat. Immunol. 2009, 10:116-125.
21. Bucasas K.L., et al. Early patterns of gene expression correlate with the humoral immune response to influenza vaccination in humans. J. Infect. Dis. 2011, 203:921-929.
22. Gaucher D., et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J. Exp. Med. 2008, 205:3119-3131.
23. Obermoser G., et al. Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines. Immunity 2013, 38:831-844.
24. Segerstrom S.C., Miller G.E. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol. Bull. 2004, 130:601-630.
25. Janeway C.A. How the immune system works to protect the host from infection: a personal view. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:7461-7468.
26. Dunn G.P., et al. Cancer immunoediting: from immunosurveillance to tumor escape. Nat. Immunol. 2002, 3:991-998.
27. Chandra R.K. Nutrition and the immune system: an introduction. Am. J. Clin. Nutr. 1997, 66:460S-463S.
28. Kau A.L., et al. Human nutrition, the gut microbiome and the immune system. Nature 2011, 474:327-336.
29. Shen-Orr S.S., Furman D. Variability in the immune system: of vaccine responses and immune states. Curr. Opin. Immunol. 2013, 25:542-547.
30. Pulendran B., et al. Systems vaccinology. Immunity 2010, 33:516-529.
31. Brodin P., et al. Variation in the human immune system is largely driven by non-heritable influences. Cell 2015, 160:37-47.
32. Franco L.M., et al. Integrative genomic analysis of the human immune response to influenza vaccination. Elife 2013, 2:e00299.
33. Pulendran B. Systems vaccinology: probing humanity's diverse immune systems with vaccines. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:12300-12306.
34. Collins F.S., Varmus H. A new initiative on precision medicine. N. Engl. J. Med. 2015, 372:793-795.
35. Hagan T., et al. Systems vaccinology: enabling rational vaccine design with systems biological approaches. Vaccine 2015, Published online April 6, 2015. 10.1016/j.vaccine.2015.03.072.
36. Plotkin S.A. Complex correlates of protection after vaccination. Clin. Infect. Dis. 2013, 56:1458-1465.
37. Vahey M.T., et al. Expression of genes associated with immunoproteasome processing of major histocompatibility complex peptides is indicative of protection with adjuvanted RTS, S malaria vaccine. J. Infect. Dis. 2010, 201:580-589.
38. US Department of Health and Human Services Guidance for Industry: Clinical Data Needed to Support the Licensure of Pandemic Influenza Vaccines 2015, Office of Communication, Training and Manufacturers Assistance.
39. Beyer W.E.P., et al. Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination?. Virus Res. 2004, 103:125-132.
40. Henn A.D., et al. High-resolution temporal response patterns to influenza vaccine reveal a distinct human plasma cell gene signature. Sci. Rep. 2013, 3:2327.
41. Furman D., et al. Cytomegalovirus infection enhances the immune response to influenza. Sci. Transl. Med. 2015, 7:281ra43.
42. Goodwin K., et al. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006, 24:1159-1169.
43. Duraisingham S.S., et al. Systems biology of vaccination in the elderly. Systems Biology 2013, 117-142. Springer. M.G. Katze (Ed.).
44. Bonhoeffer J., et al. Immunisation of premature infants. Arch. Dis. Child. 2006, 91:929-935.
45. Poland G.A., Mulligan M.J. The imperative of influenza vaccines for elderly individuals - an evolving story. J. Infect. Dis. 2009, 200:161-163.
46. Welsh R.M., Selin L.K. No one is naive: the significance of heterologous T-cell immunity. Nat. Rev. Immunol. 2002, 2:417-426.
47. Pawelec G., et al. Is immunosenescence infectious?. Trends Immunol. 2004, 25:406-410.
48. Klein S.L., et al. The Xs and Y of immune responses to viral vaccines. Lancet Infect. Dis. 2010, 10:338-349.
49. Cook I.F. Sexual dimorphism of humoral immunity with human vaccines. Vaccine 2008, 26:3551-3555.
50. Klein S.L., et al. Sex-based differences in immune function and responses to vaccination. Trans. R. Soc. Trop. Med. Hyg. 2015, 109:9-15.
51. Furman D., et al. Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:869-874.
52. Young K.M., et al. Is obesity a risk factor for vaccine non-responsiveness?. PLoS ONE 2013, 8:e82779.
53. Eliakim A., et al. Reduced tetanus antibody titers in overweight children. Autoimmunity 2006, 39:137-141.
54. Sheridan P.A., et al. Obesity is associated with impaired immune response to influenza vaccination in humans. Int. J. Obes. 2012, 36:1072-1077.
55. Poland G.A., et al. Vaccine immunogenetics: bedside to bench to population. Vaccine 2008, 26:6183-6188.
56. Tan P-L., et al. Twin studies of immunogenicity - determining the genetic contribution to vaccine failure. Vaccine 2001, 19:2434-2439.
57. Posteraro B., et al. The link between genetic variation and variability in vaccine responses: Systematic review and meta-analyses. Vaccine 2014, 32:1661-1669.
58. Roederer M., et al. The genetic architecture of the human immune system: a bioresource for autoimmunity and disease pathogenesis. Cell 2015, 161:387-403.
59. Welter D., et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res. 2014, 42:D1001-D1006.
60. Höhler T., et al. Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins. Lancet 2002, 360:991-995.
61. Orrù V., et al. Genetic variants regulating immune cell levels in health and disease. Cell 2013, 155:242-256.
62. Wang Y., et al. Effect of regulatory architecture on broad versus narrow sense heritability. PLoS Comput. Biol. 2013, 9:e1003053.
63. Rijsdijk F.V., Sham P.C. Analytic approaches to twin data using structural equation models. Brief. Bioinform. 2002, 3:119-133.
64. Dominguez-Bello M.G., et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:11971-11975.
65. Bleker O.P., et al. A study of birth weight, placental weight and mortality of twins as compared to singletons. Br. J. Obstet. Gynaecol. 1979, 86:111-118.
66. Neu J., Rushing J. Cesarean versus vaginal delivery: long term infant outcomes and the hygiene hypothesis. Clin. Perinatol. 2011, 38:321-331.
67. Dopico X.C., et al. Widespread seasonal gene expression reveals annual differences in human immunity and physiology. Nat. Commun. 2015, 6:7000.
68. Manolio T.A., et al. Finding the missing heritability of complex diseases. Nature 2009, 461:747-753.
69. Baxter A.G., Hodgkin P.D. No luck replicating the immune response in twins. Genome Med. 2015, 7:29.
70. O'Connor D., Pollard A.J. Characterizing vaccine responses using host genomic and transcriptomic analysis. Clin. Infect. Dis. 2013, 57:860-869.
71. Zuk O., et al. The mystery of missing heritability: genetic interactions create phantom heritability. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:1193-1198.
72. Raj T., et al. Polarization of the effects of autoimmune and neurodegenerative risk alleles in leukocytes. Science 2014, 344:519-523.
73. Ye C.J., et al. Intersection of population variation and autoimmunity genetics in human T cell activation. Science 2014, 345:1254665.
74. Schadt E.E., et al. An integrative genomics approach to infer causal associations between gene expression and disease. Nat. Genet. 2005, 37:710-717.
75. Shen-Orr S.S., Gaujoux R. Computational deconvolution: extracting cell type-specific information from heterogeneous samples. Curr. Opin. Immunol. 2013, 25:571-578.
76. Sallusto F., et al. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 2004, 22:745-763.
77. Sasaki S., et al. Influence of prior influenza vaccination on antibody and B-cell responses. PLoS ONE 2008, 3:e2975.
78. He X-S., et al. Baseline levels of influenza-specific CD4 memory T-cells affect T-cell responses to influenza vaccines. PLoS ONE 2008, 3:e2574.
79. Frasca D., et al. Unique biomarkers for B-cell function predict the serum response to pandemic H1N1 influenza vaccine. Int. Immunol. 2012, 24:175-182.
80. Maertzdorf J., et al. Molecular signatures for vaccine development. Vaccine 2015, Published online April 6, 2015. 10.1016/j.vaccine.2015.03.075.
81. Gomez Lorenzo M.M., Fenton M.J. Immunobiology of influenza vaccines. Chest 2013, 143:502-510.
82. Thakar J., et al. Aging-dependent alterations in gene expression and a mitochondrial signature of responsiveness to human influenza vaccination. Aging 2015, 7:38-52.
83. Germain R.N. Vaccines and the future of human immunology. Immunity 2010, 33:441-450.
84. Maecker H.T., et al. Standardizing immunophenotyping for the Human Immunology Project. Nat. Rev. Immunol. 2012, 12:191-200.
85. Benoist C., et al. Consortium biology in immunology: the perspective from the Immunological Genome Project. Nat. Rev. Immunol. 2012, 12:734-740.
86. + T cell transcription signature predicts prognosis in autoimmune disease. Nat. Med. 2010, 16:586-591.
87. Check Hayden E. The automated lab. Nature 2014, 516:131-132.
88. Whitesides G.M. The origins and the future of microfluidics. Nature 2006, 442:368-373.
89. Junkin M., Tay S. Microfluidic single-cell analysis for systems immunology. Lab Chip 2014, 14:1246-1260.
90. Klein A.M., et al. Droplet barcoding for single-cell transcriptomics applied to embryonic stem cells. Cell 2015, 161:1187-1201.
91. Macosko E.Z., et al. Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets. Cell 2015, 161:1202-1214.
92. Shi Q., et al. Single-cell proteomic chip for profiling intracellular signaling pathways in single tumor cells. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:419-424.
93. Zenobi R. Single-Cell metabolomics: analytical and biological perspectives. Science 2013, 342:1243259.
94. Bheda P., Schneider R. Epigenetics reloaded: the single-cell revolution. Trends Cell Biol. 2014, 24:712-723.
95. Cusanovich D.A., et al. Multiplex single-cell profiling of chromatin accessibility by combinatorial cellular indexing. Science 2015, 348:910-914.
96. Junker J.P., van Oudenaarden A. Every cell is special: genome-wide studies add a new dimension to single-cell biology. Cell 2014, 157:8-11.
97. Dudley J.T., et al. Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease. Sci. Transl. Med. 2011, 3:96ra76.
98. + T cells in vivo. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:1108-1113.
99. 64Cu antibody-targeting of the T-cell receptor and subsequent internalization enables in vivo tracking of lymphocytes by PET. Proc. Natl. Acad. Sci. U.S.A. 2015, 112:1161-1166.
100. Sathaliyawala T., et al. Distribution and compartmentalization of human circulating and tissue-resident memory T cell subsets. Immunity 2013, 38:187-197.
101. Thome J.J.C., et al. Spatial map of human T cell compartmentalization and maintenance over decades of life. Cell 2014, 159:814-828.
102. Shultz L.D., et al. Humanized mice for immune system investigation: progress, promise and challenges. Nat. Rev. Immunol. 2012, 12:786-798.
103. Valdez Y., et al. Influence of the microbiota on vaccine effectiveness. Trends Immunol. 2014, 35:526-537.
104. Oh J.Z., et al. TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination. Immunity 2014, 41:478-492.
105. Jackson K.J.L., et al. Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements. Cell Host Microbe 2014, 16:105-114.
106. Martins A.J., Tsang J.S. Random yet deterministic: convergent immunoglobulin responses to influenza. Trends Microbiol. 2014, 22:488-489.
107. Cao R.G., et al. Differences in antibody responses between trivalent inactivated influenza vaccine and live attenuated influenza vaccine correlate with the kinetics and magnitude of interferon signaling in children. J. Infect. Dis. 2014, 210:224-233.
108. Montgomery D.C. Design and Analysis of Experiments 2000, Wiley. (5th edn).
109. Wrammert J., et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 2008, 453:667-671.
110. Duffy D., et al. Functional analysis via standardized whole-blood stimulation systems defines the boundaries of a healthy immune response to complex stimuli. Immunity 2014, 40:436-450.
111. Ozsolak F., Milos P.M. RNA sequencing: advances, challenges and opportunities. Nat. Rev. Genet. 2011, 12:87-98.
112. Malone J.H., Oliver B. Microarrays, deep sequencing and the true measure of the transcriptome. BMC Biol. 2011, 9:34.
113. Kogenaru S., et al. RNA-seq and microarray complement each other in transcriptome profiling. BMC Genomics 2012, 13:629.
114. Kling J. Cytometry: Measure for measure. Nature 2015, 518:439-443.
115. Schwanhäusser B., et al. Global quantification of mammalian gene expression control. Nature 2011, 473:337-342.
116. Levesque-Sergerie J-P., et al. Detection limits of several commercial reverse transcriptase enzymes: impact on the low- and high-abundance transcript levels assessed by quantitative RT-PCR. BMC Mol. Biol. 2007, 8:93.
117. Mallone R., et al. Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes Society. Clin. Exp. Immunol. 2011, 163:33-49.
118. Djoba Siawaya J.F., et al. An evaluation of commercial fluorescent bead-based luminex cytokine assays. PLoS ONE 2008, 3:e2535.
119. Lynch H.E., et al. Development and implementation of a proficiency testing program for Luminex bead-based cytokine assays. J. Immunol. Methods 2014, 409:62-71.
120. Kraemer S., et al. From SOMAmer-based biomarker discovery to diagnostic and clinical applications: a SOMAmer-based, streamlined multiplex proteomic assay. PLoS ONE 2011, 6:e26332.
121. Won J-H., et al. Significance analysis of xMap cytokine bead arrays. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:2848-2853.
122. Bates, D. et al. (2014) Fitting linear mixed-effects models using lme4. ArXiv 14065823.
123. Heckerman D. A Tutorial on Learning With Bayesian Networks 1996, Learning in Graphical Models.
124. Chaussabel D., et al. A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity 2008, 29:150-164.
125. Goel G., et al. Multivariate inference of pathway activity in host immunity and response to therapeutics. Nucleic Acids Res. 2014, 42:10288-10306.
126. Lee E., et al. Inferring pathway activity toward precise disease classification. PLoS Comput. Biol. 2008, 4:e1000217.
127. Barbie D.A., et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 2009, 462:108-112.
128. Subramanian A., et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:15545-15550.
129. Irizarry R.A., et al. Gene set enrichment analysis made simple. Stat. Methods Med. Res. 2009, 18:565-575.
130. James G., et al. An Introduction to Statistical Learning: With Applications in R 2013, Springer.
131. Abbas A.R., et al. Deconvolution of blood microarray data identifies cellular activation patterns in systemic lupus erythematosus. PLoS ONE 2009, 4:e6098.